
Grünenthal partners with DKSH to bring four important pain medicines to eight new markets in Asia-Pacific28.9.2026 09:07:45 CEST | news aktuell GmbH | Press Release
The partnership will bring Qutenza®, Vimovo®, Palexia® and Zomig® to people living with pain in Asia-Pacific, spanning Hong Kong, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand and Vietnam. Pain is a significant healthcare challenge in the region, due to the ageing population and the high burden of chronic diseases.[i],[123], The partnership is a key step in Grünenthal’s strategy to enhance patient care and expand access to its innovative medicines.


















